Popular Articles
Benefits Of Grapefruit

Tiller Murder Prompts Abortion Providers To Re-Evaluate Protective Measures, Security
The recent murder of Kansas abortion provider George Tiller has prompted other providers nationwide to reassess their need for protective measures against violent actions from opponents of abortion rights, the AP/San Francisco Chronicle reports. In the days following Tiller"s murder, many clinic officials nationwide said that they had contacted law enforcement and examined their existing security measures. U.S. Attorney General Eric Holder also ordered the U.S. Marshals Service to provide security to several clinicians and facilities. According to the AP/Chronicle, violence against abortion providers in the 1980s and 1990s forced many to take various precautionary measures in and around their clinics, while some underwent training to protect themselves.Kate Michelman, former president of NARAL Pro-Choice America, said the election of former President George W. Bush, an abortion-rights opponent, helped alleviate some violence against abortion providers. However, she said that she believes Tiller"s murder might indicate the situation is changing during the first months of President Obama"s administration. Obama has rejected abortion-rights opponents" calls for restrictions on the procedure and also reversed the "global gag rule," or "Mexico City" policy.Michelman said, "Historically, when those who oppose a woman"s right to decide are frustrated politically, they get more violent," adding, "I have been thinking about this ever since the [Obama] election." She said that some providers will remain fearful even though she believes clinics are now safe. "In the end ... if someone is out to get you and they are determined and have a chorus encouraging them, ... there"s not much you can do to stop them," Michelman said. Provider LeRoy Carhart, who provided abortion services at Tiller"s clinic, said that people who commit violence against abortion providers should be charged with hate crimes (Hanna, AP/San Francisco Chronicle, 6/3).
generic viagra online
FDA Issues Complete Response Letter For INTUNIV™ (guanfacine) Extended Release For The Treatment Of ADHD In Children And Adolescents
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has received a Complete Response letter for INTUNIV TM (guanfacine) Extended Release from the Food and Drug Administration (FDA). This decision comes following labeling discussions with the FDA that did not result in agreement in time to meet the PDUFA date.
News of the day
New System Monitors Fetal Heartbeat - Noninvasive Technique Could Prevent Complications
Tiny fluctuations in a fetus"s heartbeat can indicate distress, but currently there is no way to detect such subtle variations except during labor, when it could be too late to prevent serious or even fatal complications.
Health Insurance

BioElectronics Prepares For General Surgical Recovery FDA 510(k) Premarketing Application Submission

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced the Company is currently preparing an application for 510(k) premarket notification for submission to the Food and Drug Administration (FDA) for general surgical recovery. The filing will request an indication for the adjunct of use in palliative treatment of postoperative edema and pain in superficial soft tissue. "There is overwhelming clinical data demonstrating the application of PEMF therapy significantly reduces postsurgical edema (swelling), pain and speeds healing. There are currently several devices cleared for this indication of use, but these devices are very large, expensive and are in no way portable, so they are neither practical nor marketable for surgical recovery. BioElectronics" portable version of PEMF, for which we recently were granted a patent, is very different. Our biomedical engineers have been able to shrink PEMF technology into a wearable patch that can be applied directly over the site of surgery," commented Andrew Whelan, CEO of BioElectronics. "Many surgeons are already using our products as an adjunctive therapy in the post-operative environment to speed healing and to significantly reduce, or in many cases, completely eliminate the use of narcotics, Tylenol® or acetaminophen, and NSAIDs to control surgical related pain within their patient populations." BioElectronics Corp."s RecoveryRX™ devices have already received FDA clearance for the treatment of edema following blepharoplasty, a common plastic surgery procedure. Gaining this additional FDA indication will allow the Company to market its products for use in the general surgical market, which consists of hundreds of thousands of procedures performed each year in both the ambulatory and outpatient environments. The Company recently filed with FDA for clearance to market its Allay™ Menstrual Pain Relief Patch product and is currently in process of completing numerous clinical trials designed to support additional marketing clearance applications with FDA. BioElectronics Corporation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):